NO20011006D0 - Høy-affinitets antistoffer - Google Patents

Høy-affinitets antistoffer

Info

Publication number
NO20011006D0
NO20011006D0 NO20011006A NO20011006A NO20011006D0 NO 20011006 D0 NO20011006 D0 NO 20011006D0 NO 20011006 A NO20011006 A NO 20011006A NO 20011006 A NO20011006 A NO 20011006A NO 20011006 D0 NO20011006 D0 NO 20011006D0
Authority
NO
Norway
Prior art keywords
affinity antibodies
antibodies
affinity
Prior art date
Application number
NO20011006A
Other languages
English (en)
Other versions
NO20011006L (no
Inventor
Peter Harrison
Original Assignee
Ks Biomedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ks Biomedix Ltd filed Critical Ks Biomedix Ltd
Publication of NO20011006L publication Critical patent/NO20011006L/no
Publication of NO20011006D0 publication Critical patent/NO20011006D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007Carcino-embryonic Antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20011006A 1998-08-28 2001-02-27 Høy-affinitets antistoffer NO20011006D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818915.2A GB9818915D0 (en) 1998-08-28 1998-08-28 Antibodies
PCT/GB1999/002729 WO2000012556A1 (en) 1998-08-28 1999-08-20 High-affinity antibodies

Publications (2)

Publication Number Publication Date
NO20011006L NO20011006L (no) 2001-02-27
NO20011006D0 true NO20011006D0 (no) 2001-02-27

Family

ID=10838074

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011006A NO20011006D0 (no) 1998-08-28 2001-02-27 Høy-affinitets antistoffer

Country Status (21)

Country Link
EP (1) EP1107990A1 (no)
JP (1) JP2002525082A (no)
KR (1) KR20010089174A (no)
CN (1) CN1315966A (no)
AU (1) AU5435099A (no)
BG (1) BG105294A (no)
BR (1) BR9913303A (no)
CA (1) CA2340865A1 (no)
EA (1) EA200100287A1 (no)
GB (1) GB9818915D0 (no)
HR (1) HRP20010149A2 (no)
HU (1) HUP0103233A3 (no)
ID (1) ID28905A (no)
IL (1) IL141523A0 (no)
MX (1) MXPA01002248A (no)
NO (1) NO20011006D0 (no)
PL (1) PL346472A1 (no)
TR (1) TR200100643T2 (no)
WO (1) WO2000012556A1 (no)
YU (1) YU15401A (no)
ZA (1) ZA200101573B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031284D0 (en) * 2000-12-21 2001-01-31 Ks Biomedix Ltd High affinity antibodies
GB0112844D0 (en) * 2001-05-25 2001-07-18 Psimei Pharmaceuticals Plc Neutron capture therapy
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
AU2003256266A1 (en) * 2002-06-12 2003-12-31 Genencor International, Inc. Methods and compositions for milieu-dependent binding of a targeted agent to a target
EP1691763A4 (en) * 2003-12-12 2008-03-12 Genencor Int CAB MOLECULES
CN111848790B (zh) * 2020-08-07 2022-02-22 上海交通大学 一种牛源抗金黄色葡萄球菌的单链抗体及其制备和应用
CN112724255A (zh) * 2021-01-28 2021-04-30 成都金昆生物科技有限公司 靶向癌胚抗原的小分子抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081235A (en) * 1989-07-26 1992-01-14 City Of Hope Chimeric anti-cea antibody
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method

Also Published As

Publication number Publication date
HUP0103233A2 (hu) 2001-12-28
CN1315966A (zh) 2001-10-03
PL346472A1 (en) 2002-02-11
HRP20010149A2 (en) 2002-02-28
IL141523A0 (en) 2002-03-10
EA200100287A1 (ru) 2001-08-27
BG105294A (bg) 2001-12-29
NO20011006L (no) 2001-02-27
TR200100643T2 (tr) 2001-07-23
HUP0103233A3 (en) 2003-10-28
ZA200101573B (en) 2002-02-26
EP1107990A1 (en) 2001-06-20
MXPA01002248A (es) 2002-05-08
CA2340865A1 (en) 2000-03-09
YU15401A (sh) 2003-07-07
GB9818915D0 (en) 1998-10-21
JP2002525082A (ja) 2002-08-13
BR9913303A (pt) 2001-10-09
ID28905A (id) 2001-07-12
WO2000012556A1 (en) 2000-03-09
KR20010089174A (ko) 2001-09-29
AU5435099A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69829040D1 (de) Elektroplattierungschemie
DE69933567D1 (de) Sigmidoskop
DE69938581D1 (de) Coriolismassendurchflussmesser
ID23458A (id) Bentuk sediaan nefazodon
DE69902034D1 (de) Lattenkollimator
DK1140127T3 (da) Antiprotozosaponiner
DE69939653D1 (de) Erkstoff
FI980202A0 (fi) Svaengningsomvandlarenhet
DE69907576D1 (de) Solenoidantriebsvorrichtung
DE69904766D1 (de) Kodenübersetzer
FI980564A0 (fi) Volymregleringsorgan foer stroemningsroer
NO20011006L (no) Höy-affinitets antistoffer
ATE295417T1 (de) Angiostatin-bindendes protein
NO20002555D0 (no) Skjøt
DE59903616D1 (de) Rollenwicklerwalze
ID24110A (id) Pembuatan rutenium kompleks
FI980974A0 (fi) Pullon suljin
IT246432Y1 (it) Culla-divanletto
DE69901909D1 (de) Kinevideokamera
FI3554U1 (fi) Teline
DK1088069T3 (da) Angiostatin-bindende protein
FI3880U1 (fi) Tarjoilusetti
ATE263775T1 (de) Hydroboronationsverfahren
ITRA980004U1 (it) X
ITRA980006U1 (it) X

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application